Widespread use of PCV13, which covers additional serotypes ... After the introduction of pneumococcal conjugate vaccine (PCV)-7, emergence of non-PCV7 serotypes, especially 19A, is prominent ...

VAX-31’s safety, tolerability, and immunogenicity are being assessed in this trial on healthy infants. Vaxcyte anticipat ...

The pneumococcal conjugate vaccine – codenamed PCV21 ... Pfizer's Prevnar franchise dominates the child and adult pneumococcal vaccine category, with sales of $4.85 billion in the first nine ...

The 15-valent conjugate vaccine was at least as effective ... to steal a march on Pfizer in the large paediatric pneumococcal vaccine category, as its rival is around a year away from reporting ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

With this addition, the Sultanate's immunisation programme now includes 12 vaccines to prevent 12 vaccine-preventable diseases. Vaccinations under the programme are provided free of charge at Maternal ...

The pneumococcal conjugate vaccine (PCV13) should be administered first, followed by the pneumococcal polysaccharide vaccine (PPSV23) after one year for at-risk individuals or eight weeks for those at ...

For example, the conjugate pneumococcal vaccine for children (Prevnar), the highest-revenue-generating vaccine, has annual gross U.S. sales of about $1 billion. But markets for cholesterol ...

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

Credit: Gorodenkoff / Shutterstock. Vaxcyte has advanced to the Phase II trial’s second and final stage (Stage 2) assessing its 31-valent pneumococcal conjugate vaccine (PCV) candidate, VAX-31 with ...

Pneumococcal vaccine – This is important to prevent the preventable strains of pneumonia, bloodstream infections, and meningitis. We recommend PCV13 and PPSV23 for adults. Tdap vaccine – This vaccine ...